2020
DOI: 10.1111/jdv.17022
|View full text |Cite
|
Sign up to set email alerts
|

Metascoring Hidradenitis suppurativa

Abstract: Funding sources: none Acknowledgments: several authors of this publication (both departments) are members of the European Reference Network for rare skin diseases. Conflict of interest: M. Daoud has nothing to disclose. H. Njimi has nothing to disclose. F. Benhadou has nothing to disclose. M. Suppa has nothing to disclose. M. Daxhelet has nothing to disclose. J. Karama has nothing to disclose. J. White has nothing to disclose. G.B.E. Jemec has nothing to disclose. V. del Marmol has nothing to disclose.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 10 publications
0
1
0
Order By: Relevance
“…The metascore ( 48 ) is a combination of the other scores mentioned, and is designed to be applied at the cohort (group) level, not at the patient level. Provided that the scores that the investigator wishes to evaluate are known, a cohort of patients could be classified from the most severely affected to the least severely affected patient (static metascore).…”
Section: Resultsmentioning
confidence: 99%
“…The metascore ( 48 ) is a combination of the other scores mentioned, and is designed to be applied at the cohort (group) level, not at the patient level. Provided that the scores that the investigator wishes to evaluate are known, a cohort of patients could be classified from the most severely affected to the least severely affected patient (static metascore).…”
Section: Resultsmentioning
confidence: 99%